Paliperidone (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Paliperidone drug offered from Mylan Pharmaceuticals Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | paliperidone |
SUBSTANCE NAME: | PALIPERIDONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Atypical Antipsychotic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-09-24 |
END MARKETING DATE: | 0000-00-00 |
Paliperidone HUMAN PRESCRIPTION DRUG Details:
Item Description | Paliperidone from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.5(mg/1) |
START MARKETING DATE: | 2015-09-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-3978_7b7e493b-4cc9-4467-b9c3-9ea4c45d7c01 |
PRODUCT NDC: | 0378-3978 |
APPLICATION NUMBER: | ANDA203802 |
Other PALIPERIDONE Pharmaceutical Manufacturers / Labelers: